-
EP2305694
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP2305694
| EP2305694 - Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 20.11.2015 Database last updated on 26.07.2024 | Most recent event Tooltip | 20.11.2015 | Application deemed to be withdrawn | published on 23.12.2015 [2015/52] | Applicant(s) | For all designated states SRI International 333 Ravenswood Avenue Menlo Park, CA 94025-3493 / US | [2011/14] | Inventor(s) | 01 /
Tanabe, Masato 972 Moreno Palo Alto, CA 94303 / US | 02 /
Peters, Richard H. 365 Springpark Circle San Jose, CA 95136 / US | 03 /
Chao, Wan-Ru 1510 Oriole Avenue Sunnyvale, CA 94087 / US | 04 /
Jong, Ling 681 Endicott Drive Sunnyvale, Ca 94087 / US | [2011/16] | Representative(s) | Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte Hamborner Straße 53 40472 Düsseldorf / DE | [N/P] |
| Former [2013/29] | Viering, Jentschura & Partner Kennedydamm 55 / Roßstrasse 40476 Düsseldorf / DE | ||
| Former [2011/14] | Mallalieu, Catherine Louise D Young & Co LLP 120 Holborn London EC1N 2DY / GB | Application number, filing date | 10177213.5 | 23.12.1998 | [2011/14] | Priority number, date | US19970998877 | 24.12.1997 Original published format: US 998877 | [2011/14] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP2305694 | Date: | 06.04.2011 | Language: | EN | [2011/14] | Type: | A3 Search report | No.: | EP2305694 | Date: | 17.04.2013 | Language: | EN | [2013/16] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 20.03.2013 | Classification | IPC: | C07J41/00, A61K31/57, C07J43/00, A61K31/56, A61K31/575, A61K31/58, A61P5/32 | [2011/14] | CPC: |
C07J41/00 (EP,KR,US);
A61P11/00 (EP);
A61P15/02 (EP);
A61P15/04 (EP);
A61P15/08 (EP);
A61P15/12 (EP);
A61P15/14 (EP);
A61P17/00 (EP);
A61P19/08 (EP);
A61P19/10 (EP);
A61P3/06 (EP);
A61P35/00 (EP);
A61P43/00 (EP);
A61P5/32 (EP);
A61P9/12 (EP);
C07J41/0072 (EP,US);
C07J41/0077 (EP,US);
C07J43/003 (EP,US);
A61K9/02 (EP,US)
(-)
| Designated contracting states | DE, FR, GB, IT, NL [2011/14] | Title | German: | Anti-östrogene Steroide, pharmazeutische Zusammensetzungen und Verwendungen davon | [2011/14] | English: | Novel anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use | [2011/14] | French: | Nouveaux stéroides anti-oestrogènes, compositions pharmaceutiques associées et leur mode d'utilisation | [2011/14] | Examination procedure | 17.07.2013 | Amendment by applicant (claims and/or description) | 17.07.2013 | Examination requested [2013/35] | 08.04.2014 | Despatch of a communication from the examining division (Time limit: M04) | 30.07.2014 | Reply to a communication from the examining division | 01.07.2015 | Application deemed to be withdrawn, date of legal effect [2015/52] | 03.08.2015 | Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time [2015/52] | Parent application(s) Tooltip | EP03000183.8 / EP1310509 | EP07015863.9 / EP1847548 | EP98964882.9 / EP1056768 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP19980964882) is 17.04.2001 | Fees paid | Renewal fee | 03.12.2010 | Renewal fee patent year 03 | 03.12.2010 | Renewal fee patent year 04 | 03.12.2010 | Renewal fee patent year 05 | 03.12.2010 | Renewal fee patent year 06 | 03.12.2010 | Renewal fee patent year 07 | 03.12.2010 | Renewal fee patent year 08 | 03.12.2010 | Renewal fee patent year 09 | 03.12.2010 | Renewal fee patent year 10 | 03.12.2010 | Renewal fee patent year 11 | 03.12.2010 | Renewal fee patent year 12 | 03.12.2010 | Renewal fee patent year 13 | 27.12.2011 | Renewal fee patent year 14 | 26.12.2012 | Renewal fee patent year 15 | 27.12.2013 | Renewal fee patent year 16 | Penalty fee | Additional fee for renewal fee | 31.12.2014 | 17 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US3271392 (YVON LEFEBVRE) [A] 1-15 * the whole document *; | [X]US3405147 (COUNSELL RAYMOND E, et al) [X] 1,2,14 * column 2, lines 24-31; examples 7-9 *; | [X]US3431258 (LEFEBVRE YVON, et al) [X] 1,2 * example 2 *; | [A]US3946052 (CROWE DAVID F, et al) [A] 1-15* page 1, lines 50-67; examples 1-10; claim 1 *; | [X] - PETERS R H ET AL, "17-DESOXY ESTROGEN ANALOGUES", JOURNAL OF MEDICINAL CHEMISTRY, (198907), vol. 32, no. 7, pages 1642 - 1652, XP002005625 [X] 1,2 * page 1646; compound 24 * DOI: http://dx.doi.org/10.1021/jm00127a040 | [A] - POIRIER D ET AL, "D-ring alkylamide derivatives of estradiol: effect on ER-binding affinity and antiestrogenic activity", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, (19961105), vol. 6, no. 21, pages 2537 - 2542, XP004135909 [A] 1-15 * page 2538; compound 4 * * page 2540; table 2 * DOI: http://dx.doi.org/10.1016/0960-894X(96)00472-6 | [A] - EL GARROUJ ET AL, "Steroidal Affinity Labels of the Estrogen Receptor. 2. 17.alpha.-[(Haloacetamido)alkyl]estradiols", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19950623), vol. 38, no. 13, doi:10.1021/JM00013A011, ISSN 0022-2623, pages 2339 - 2348, XP002109818 [A] 1-15 * page 2341; compounds 19,21,23 * * page 2342; table I * DOI: http://dx.doi.org/10.1021/jm00013a011 | [A] - ALIAU ET AL, "17.alpha.-(Haloacetamidoalkyl)estradiols alkylate the human estrogen receptor at cysteine residues 417 and 530", BIOCHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, (19970513), vol. 36, no. 19, doi:10.1021/BI963111C, ISSN 0006-2960, pages 5861 - 5867, XP002109819 [A] 1-15 * page 5862, column 1; figure 1; compounds 2B, 3B, 3I * * page 5864, column 2, paragraph 2 * DOI: http://dx.doi.org/10.1021/bi963111c | by applicant | US2840581 | FR3031M | FR1453210 | US3536703 | US3710795 | US3716530 | US5447941 | US5510370 | US5552416 | US5578613 | US5578614 | US5593987 | US5610167 | US5641790 | US5646137 | US5663184 | US5719165 | RU58668U | - WAKELING ET AL., J. STEROIDBIOCHEM, (1988), vol. 31, pages 645 - 653 | - WAKELING ET AL., CANCER RES., (1991), vol. 51, pages 3867 - 3873 | - WAKELING ET AL., J. STEROID BIOCHEM. MOLEC. BIOL., (1990), vol. 37, pages 771 - 774 | - VAN DE VELDE ET AL., ANN. N.Y. ACAD SCI., (1995), vol. 761, pages 164 - 175 | - VAN DE VELDE, PATHOL. BIOL., (1994), vol. 42, page 30 | - NIQUE ET AL., DRUGS FUTURE, (1995), vol. 20, pages 362 - 366 | - BLICKENSTAFF ET AL., STEROIDS, (1985), vol. 46, no. 4,5, pages 889 - 902 | - QIAN ET AL., J. STEROIDBIOCHEM., (1988), vol. 22, no. 6, pages 657 - 664 | - GRESE ET AL., "Synthesis and Pharmacology of Conformationally Restricted Raloxifene Analogues: Highly Potent Selective Estrogen Receptor Modulators", J. MED CHEM., (1998), vol. 41, pages 1272 - 1283 | - BRYANT ET AL., "Selective Estrogen Receptor Modulators: An Alternative to Hormone Replacement Therapy", J. SOC. FOR EXPER. BIOL. AND MEDICINE, (1998), pages 45 - 52 | - KE ET AL., "Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus and Body Composition in Rat Models", ENDOCRINOLOGY, (1998), vol. 139, no. 4, pages 2068 - 2076 | - KAUFFINAN ET AL., "Hypocholesterolemic Activity ofRaloxifene (LY139481): Pharmacological Characterization as a Selective Estrogen Receptor Modulator", J. PHARMACOL. EXPERIMENTAL THERAP., (1997), vol. 280, no. 1, pages 146 - 153 | - FRIED ET AL., Orgpnic Reactions in Steroid Chemistry, NEW YORK: REINHOLD, (1972), vol. I, II | - LITTLEFIELD ET AL., ENDOCRINOLOGY IM, (1990), pages 2757 - 2762 | - WAKELING ET AL., ENDOCRINOLOGY, (1983), vol. 99, pages 447 - 453 | - ""Analysis of Sebaceous Lipids"", SKERROW, D. AND SKERROW, C.J., Methods in Skin Research, JOHN WILEY & SONS LTD., (1985), pages 587 - 608 | US19970997416 |